Position in AVXL
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$325,843
-$56,515 QoQ
Shares Held
106,138
-1.2% QoQ
Ownership
0.115%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 23%
Shared 0%
None 77%
Common Shares in AVXL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,237,848,251 across 287 Biotechnology names. AVXL ranks #182 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
423,140 | $188,948,935 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,781 | $121,907,911 | |
| 3 | INCY |
Incyte Corp
|
693,665 | $65,287,749 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
195,277 | $64,611,300 | |
| 5 | INSM |
INSMED Inc
|
272,615 | $44,578,004 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
164,542 | $31,106,665 | |
| 7 | EXEL |
Exelixis, Inc.
|
723,931 | $31,049,400 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,113,266 | $30,837,468 |
All Filings in AVXL
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $325,843 | 106,138 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $382,358 | 107,404 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,103,564 | 123,996 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,183,571 | 128,370 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,038,119 | 120,993 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $1,328,527 | 123,699 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $682,741 | 120,201 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $503,399 | 119,289 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $524,249 | 102,996 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $934,947 | 100,424 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $649,026 | 99,088 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $830,381 | 102,138 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $767,177 | 89,519 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $799,063 | 86,292 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $866,591 | 83,972 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $770,149 | 76,938 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $837,289 | 68,017 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,059,664 | 61,111 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,083,354 | 60,354 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,328,074 | 58,096 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $756,365 | 50,593 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $245,980 | 45,552 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $189,744 | 41,702 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $248,519 | 50,512 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $104,343 | 33,125 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||